We hereby submit Investor''s Presentation for Q2FY27.

YH/SE/67/2026-27 November 03, 2026 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 Phiroze Jeejeebhoy Towers, G Block, Bandra-Kurla Complex, Bandra (E) Dalal Street, Mumbai – 400 051, India Mumbai -400001, India Symbol: YATHARTH Scrip Code: 543950 ISIN: INE0JO301016 ISIN: INE0JO301016 Sub: Investor's Presentation- Q2FY27 Results Dear Sir/Ma’am, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor’s Presentation on financial results of the Company for Q2FY27. The above presentation will also be available on the Company’s website at https://www.yatharthhospitals.com/investors/corporate-announcements This is for your kind information and records. Thanking You Yours Faithfully, For Yatharth Hospital & Trauma Care Services Limited Ritesh Mishra Company Secretary & Compliance Officer M. No. A51166 Encl.: A/a Q2 & H1 FY27 Investor Presentation November 3, 2026 With strategic investment from HOSPITALS Disclaimer Certain matters discussed in this presentation may contain statements regarding the company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements does not guarantee future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the economy, industry, competition, the company’s ability to successfully implement its strategy, technological implementation, changes and advancements, the company’s market preferences and its exposure to market risks, as well as other risks. The company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this presentation. The company assumes no obligation to update any forward-looking information contained in this presentation. Any forward-looking statements and projections made by third parties included in this presentation are not adopted by the company and the company is not responsible for such third-party statements and projections. You are cautioned not to place undue reliance on these forward-looking statements, which are based on the current view of the management of the Company on future events. Q2 FY27 Performance provides a Solid Foundation for the Next Phase Revenue EBITDA EBITDA Margin Cash Profits2 PAT Rs 4,314 mn Rs 1,020 mn 23.6% Rs 816 mn Rs 485 mn +52% YoY | +10% QoQ +50% YoY | +11% QoQ Adjusted EBITDA1 ~28% +36% YoY | +11% QoQ +17% YoY | +7% QoQ ARPOB ALOS Bed Capacity3 Operational Census4 Occupancy4 Rs 35,948 3.33 2,800+ beds 1,820 beds 72% +11% YoY 1. Adjusted EBITDA Margin is presented to exclude the impact of ramp-up from newer hospitals – Model Town and Faridabad Sector-20 2. Cash Profit (Profit After Tax plus Depreciation) excludes the impact of depreciation costs from the ongoing ramp-up of newer hospitals 3. Bed Capacity is including the newly acquired under-construction hospital in Gurugram (250 beds) 4. Occupancy is based on currently operational census beds. As the New Delhi, Faridabad Sec-20, Agra and Gurugram hospitals are yet to fully ramp up, census beds will increase progressively H1 FY27: Sustained Growth and Operational Momentum Revenue EBITDA EBITDA Margin PAT Rs 8,241 mn Rs 1,937 mn 23.5% Rs 939 mn +52% YoY +44% YoY Adjusted EBITDA1 ~28% Cash Profits2 +33% YoY Bed Capacity3 Occupancy4 ARPOB ALOS 2,800+ beds 70% Rs 35,371 3.51 days +9% YoY Operating Cash Flow Cash Conversion Ratio Total Cash RoCE Rs 1,113 mn 57% Rs 4,289 mn +49% YoY Net Debt Rs 392 mn 1. Adjusted EBITDA Margin is presented to exclude the impact of ramp-up from newer hospitals – Model Town and Faridabad Sector-20 2. Cash Profit (Profit After Tax plus Depreciation) excludes the impact of depreciation costs from the ongoing ramp-up of newer hospitals 3. Bed Capacity is including the newly acquired under-construction hospital in Gurugram (250 beds) 4. Occupancy is based on currently operational census beds. As the New Delhi, Faridabad Sec-20, Agra and Gurugram hospitals are yet to fully ramp up, census beds will increase progressively A Strong Quarter, marking the Beginning of a New Chapter Existing Hospitals1 driving New Hospitals1 driving Noida Ext & Model Town achieves Stronger Profits Robust Growth Approx 50k ARPOB Platform Strength ~28%+ EBITDA margins 28% in Revenue Mix vs 11% in Q2 FY26 Gurugram to start with 50k Stronger Team Governance Diverse Board Institutional Development KMPs. Hospital CEOs & Stronger Guardrails, with Leading Reputed Veterans on Board Medical Directors Auditors, Systems & Processes Advent Rs 3,150 crore Global Expertise Strategic Partnership with Advent to hold 24.9% strategic stake Primary Capital Infusion Acquisition & Scaling Capabilities 1. New Hospitals comprises of Greater Faridabad, New Delhi Model Town, Faridabad Sector-20, and Agra 5 Advent’s Partnership marks a New Chapter in Yatharth’s Growth Journey Yatharth Hospitals’ Proven Platform + Advent’s Global Experience and Value-creation Capabilities Rs 3,150 Cr Advent Promoter 24.9% Primary Capital Global Private Family to remain the Investment Minority Stake Equity Partner Largest Shareholder (Awaiting regulatory at ~42%, post dilution approvals) ADVENT GLOBAL CREDENTIALS STRATEGIC SIGNIFICANCE Over US $109 Bn Assets under management Proven Healthcare Platform Strategic Global Expertise Continuity with Acceleration Investments in 45 countries Reflects Advent’s confidence in Advent brings deep healthcare The Tyagi family remains the Yatharth’s differentiated expertise, global experience largest shareholder and healthcare platform, strong and institutional knowledge continues to guide its long- 55+ clinical capabilities, a scalable and a long-term value- term vision, supported by the Healthcare investments operating model and an creation mindset to support existing leadership team experienced leadership team the next phase of growth 35+ Years Healthcare experience Record Revenue & EBITDA growth Operating margins improve sequentially as newer hospitals ramp up and turn profitable Revenue (Rs mn) EBITDA (Rs mn) 11223344556 ,,,,,,,,,,, 05050505050 00000000000 00000000000 0 3 8 7 2 9 , 3 + +5 1 4 1 3 , 402 %% QY oo QY 2 4 , 5 82% YoY 11 11111111111 11111111111111 11111111111111 1111 11111111 11 11 111111111111 ,,1111 ,,,,,,,,,,, 1111 ,,,,,,,,,,,,,, 11 ,,,,,,,,,,,,,, ,,,, 00,,,,,, 0000000000,,4 00,,333333333333 44444444444455555555555566666666666688888888888899999999999900222222222222 0033 22333333333333445566668899222233 22222222224455889933 223333445566777777777777889922 2211,, 22337777,,,,,,,,,,,, 77,,,, ,,,, ,,11 001111111111 1133 11111111111144556688991122 11 1133 1122 1177,,004455668899 11 00445566889900445566889900445566889900445566889900445566889966004455668899 6611004455889933 66004455668899 445588993333223333336633223322 0044556688990044558899 332222222222 0044558899770 3322004455668899 227777777777 33337777 772222 227777223377 777711 111111111111 11 11111111 110505050505050505 05050505050505 0505 05050505050505 0505 0505050505050505050505050505 050505050505050505 05 0505050505050505050505050505050505050505 0505050505 050505050505050 0505050505050505050505 050505050505050505050505 0505050505050505050505050505050505050505050505050505050505050505 0505 1 8 6 7 1 9 + +5 1 2 0 , 110 %% Q Y oo QY 22222222222222222222222 2222222222222222222222222 2222222222 22222222222222222222 222222 22222 222 1111111111111111111111111111111111111111111 1111111 11111111111111111111111111111111111222222222222222222 11111111111 1111111111111111122 1111111222222 11111222 111111222 11 111111111111111,,,,,,,,,,,,,,,,,,,,,,, 11 ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 1111111111111111122 ,,,,,,,,,,,,,,,,,,,, [Showing first 8,000 characters — download PDF for full document]